BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24811250)

  • 1. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
    Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
    PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
    Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
    Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.
    Zhu W; Sun W; Zhang JT; Liu ZY; Li XP; Fan YZ
    Int J Oncol; 2015 Feb; 46(2):627-40. PubMed ID: 25405519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
    Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD
    Molecules; 2019 May; 24(10):. PubMed ID: 31109130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.
    Sun W; Fan YZ; Zhang WZ; Ge CY
    J Exp Clin Cancer Res; 2011 Apr; 30(1):46. PubMed ID: 21529356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression.
    Wang Z; You D; Lu M; He Y; Yan S
    Oncol Lett; 2017 Mar; 13(3):1660-1664. PubMed ID: 28454306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse.
    Huang SM; Hsu PC; Chen MY; Li WS; More SV; Lu KT; Wang YC
    Int J Cancer; 2012 Aug; 131(3):722-32. PubMed ID: 22015944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
    Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
    Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):603-7. PubMed ID: 15567755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    World J Gastroenterol; 2005 Apr; 11(16):2431-7. PubMed ID: 15832413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.
    Du T; Qu Y; Li J; Li H; Su L; Zhou Q; Yan M; Li C; Zhu Z; Liu B
    Mol Cancer; 2014 May; 13():100. PubMed ID: 24885567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.